Four-dollar generics--increased accessibility, impaired quality assurance

N Engl J Med. 2010 Nov 11;363(20):1885-7. doi: 10.1056/NEJMp1006189.

Authors

Niteesh K Choudhry¹, William H Shrank

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.

PMID: 21067379
DOI: 10.1056/NEJMp1006189

No abstract available

MeSH terms

Clinical Pharmacy Information Systems / organization & administration
Drug Costs
Drugs, Generic / economics*
Health Services Accessibility / economics
Humans
Insurance Benefits
Insurance, Pharmaceutical Services
Patient Compliance
Pharmaceutical Services / economics*
Pharmaceutical Services / organization & administration
Quality Assurance, Health Care*
Reimbursement Mechanisms / organization & administration
United States

Substances

Drugs, Generic